Apitope starts new ATX-MS-1467 clinical trial

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Apitope starts new ATX-MS-1467 clinical trial

Postby MSUK » Tue May 18, 2010 6:22 am

Apitope, the European biotech company developing therapeutic peptides to treat autoimmune and allergic diseases, today announced the start of its second Phase I clinical trial of ATX-MS-1467, in patients with Multiple Sclerosis (MS)...............

http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2341
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 1981
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Postby LR1234 » Tue May 18, 2010 6:26 am

By the Way Squiffs, I like it when you start new topics for each link. I can easily refind them and can read the ones I want. Also each one is a new topic, so I think each one should have a thread of discussion.:)
LR1234
Family Elder
 
Posts: 1492
Joined: Wed Feb 11, 2009 4:00 pm
Location: California

Postby Bethr » Tue May 18, 2010 11:48 am

I agree. Best to start a new thread for each item as the subject matter can be very different.

Cheers.....
User avatar
Bethr
Family Elder
 
Posts: 475
Joined: Sun Dec 27, 2009 4:00 pm


Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users